Clinical Trials List
Protocol NumberCSBR759A2305
2009-10-12 - 2010-08-17
Phase III
Terminated2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 顧進裕 Division of Nephrology
- 郭美娟 Division of Nephrology
- 蔡哲嘉 Division of Nephrology
- Shang-Jyh Hwang Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 邱鼎育 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
500 participants
